Chemoinformaics analysis of (2S,3R,5Z)-5-ethylidene-2-hydroxy-2-(hydroxymethyl)-3-methylhexanedioic acid
Molecular Weight | 232.232 | nRot | 6 |
Heavy Atom Molecular Weight | 216.104 | nRig | 3 |
Exact Molecular Weight | 232.095 | nRing | 0 |
Solubility: LogS | -0.396 | nHRing | 0 |
Solubility: LogP | -0.166 | No. of Aliphatic Rings | 0 |
Acid Count | 2 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
nHA | 4 | APOL | 32.1807 |
nHD | 4 | BPOL | 17.7873 |
QED | 0.473 |
Synth | 4.049 |
Natural Product Likeliness | 1.498 |
NR-PPAR-gamma | 0.008 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.014 |
HIA | 0.04 |
CACO-2 | -5.936 |
MDCK | 0.00337451 |
BBB | 0.184 |
PPB | 0.2588 |
VDSS | 0.363 |
FU | 0.528485 |
CYP1A2-inh | 0.017 |
CYP1A2-sub | 0.056 |
CYP2c19-inh | 0.022 |
CYP2c19-sub | 0.046 |
CYP2c9-inh | 0.02 |
CYP2c9-sub | 0.11 |
CYP2d6-inh | 0.013 |
CYP2d6-sub | 0.112 |
CYP3a4-inh | 0.021 |
CYP3a4-sub | 0.026 |
CL | 2.208 |
T12 | 0.864 |
hERG | 0.012 |
Ames | 0.016 |
ROA | 0.044 |
SkinSen | 0.4 |
Carcinogencity | 0.015 |
EI | 0.967 |
Respiratory | 0.029 |
NR-Aromatase | 0.075 |
Antiviral | No |
Prediction | 0.904396 |